Fol. Biol. 2008, 54, 53-57
https://doi.org/10.14712/fb2008054020053
Methylenetetrahydrofolate Reductase C677T Gene Polymorphism in Osteosarcoma and Chondrosarcoma Patients
References
1. 2004) Reduced breast cancer risk with increasing serum folate in a casecontrol study of the C677T genotype of the methylenetetrahydrofolate reductase gene. Eur. J. Cancer 40, 1250-1254.
< , J., Ingram, D., Hahnel, R., Rossi, E. (https://doi.org/10.1016/j.ejca.2004.01.026>
2. 2002) Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res. 4, R14.
< , I. G., Baxter, S. W., Eccles, D. M., Choong, D. Y. (https://doi.org/10.1186/bcr457>
3. 1996) A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56, 4862-4864.
, J., Giovannucci, E., Kelsey, K., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Spiegelman, D., Willett, W. C., Hunter, D. J. (
4. 1998) DNA hypomethylation leads to elevated mutation rates. Nature 395, 89-93.
< , R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., Jaenisch, R. (https://doi.org/10.1038/25779>
5. 2002) Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate. Ann. Oncol. 13, 1915-1918.
< , P., Reddiconto, G., Casorelli, I., Laurenti, L., Sora, F., Mele, L., Annino, L., Leone, G., Sica, S. (https://doi.org/10.1093/annonc/mdf322>
6. 1998) DNA instability (strand breakage, uracil misincorporation and defective repair) is increased by folic acide depletion in human lymphocytes in vitro. FASEB J. 12, 1491-1497.
< , S. J., Hawdon, A. (https://doi.org/10.1096/fasebj.12.14.1491>
7. 1997) Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 18, 2307-2311.
< , M., Garcia, A., Martinez-Palones, J. M., Xercavins, J., Reventos, J. (https://doi.org/10.1093/carcin/18.12.2307>
8. 1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48, 1159-1161.
, A. P., Gehrke, C. W., Kuo, K. C., Ehrlich, M. (
9. 1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10, 111-113.
< , P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J., Den Heijer, M., Kluıjtmans, L. A., Van Den Heuvel, L. P. (https://doi.org/10.1038/ng0595-111>
10. 2000) Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur. Cancer 36, 2313-2316.
< , R., Dagan, E., Israeli, D., Kasinetz, L., Kadouri, E., Friedman, E. (https://doi.org/10.1016/S0959-8049(00)00306-3>
11. 1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 28, 187-190.
< , S. E., Vogelstein, B., Hamilton, S. R., Feinberg, A. P. (https://doi.org/10.1126/science.2579435>
12. 1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7-9.
< , P. F., Bostom, A. G., Williams, R. R., Ellison, R. C., Eckfeldt, J. H., Rosenberg, I. H., Selhub, J., Rozen, R. (https://doi.org/10.1161/01.CIR.93.1.7>
13. 1994) In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Res. 54, 5075-5080.
, S. J., Basnakian, A. G., Miller, B. J. (
14. 1996) Exon-specific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine. Modulation by dietary folate. Am. J. Pathol. 149, 1129-1137.
, Y. I., Pogribny, I. P., Salomon, R. N., Choi, S. W., Smith, D. E., James, S. J., Mason, J. B. (
15. 2004) Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J. 4, 66-72.
< , M., Lemieux-Blanchard, E., Chiasson, S., Primeau, M., Costea, I., Moghrabi, A. (https://doi.org/10.1038/sj.tpj.6500224>
16. 1999) CpG islands in chromatin organization and gene expression. J. Biochem. 125, 217-222.
< , T. K., Rao, M. R. (https://doi.org/10.1093/oxfordjournals.jbchem.a022276>
17. 1997) DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 94, 2545-2550.
< , C., Kinzler, K. W., Vogelstein, B. (https://doi.org/10.1073/pnas.94.6.2545>
18. 1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 57, 1098-1102.
, J., Stampfer, M. J., Giovannucci, E., Artigas, C., Hunter, D. J., Fuchs, C., Willett, W. C., Selhub, J., Hennekens, C. H., Rozen, R. (
19. 2000) Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas. Cancer Lett. 151, 181-186.
< , T., Tsuji, E., Inoue, H., Shinomiya, S., Kiyohara, C., Onuma, K., Hamada, H., Koga, H., Handa, K., Hayabuchi, H., Kono, S. (https://doi.org/10.1016/S0304-3835(99)00412-7>
20. 2004) Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J. Bone Miner. Res. 19, 410-418.
< , R. R., Karasik, D., Selhub, J., Tucker, K. L., Ordovas, J. M., Russo, G. T., Cupples, L. A., Jacques, P. F., Kiel, D. P. (https://doi.org/10.1359/JBMR.0301261>
21. 1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
< , S. A., Dykes, D. D., Polesky, H. S. (https://doi.org/10.1093/nar/16.3.1215>
22. 1999) Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 8, 513-518.
, M. L., Potter, J. D., Samowitz, W., Schaffer, D., Leppert, M. (
23. 2003) Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int. J. Cancer 103, 294-299.
< , G., Russo, A., Innocenti, F., Corona, G., Tumolo, S., Sartor, F., Mini, E., Boiocchi, M. (https://doi.org/10.1002/ijc.10847>
24. 2001) Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol. Sci. 22, 195-201.
< , P. M., Hustad, S., Schneede, J., Refsum, H., Stein, S. E. (https://doi.org/10.1016/S0165-6147(00)01675-8>
25. 2000) Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps. Cancer Epidemiol. Biomarkers Prev. 9, 427-433.
, C. M., Kampman, E., Bigler, J., Schwartz, S. M., Chen, C., Bostick, R., Fosdick, L., Beresford, S. A. A., Yasui, Y., Potter, J. D. (
26. 2004) Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: The Fukuoka Colorectal Cancer Study. Cancer Sci. 95, 908-913.
< , G., Kono, S., Toyomura, K., Hagiwara, T., Nagano, J., Mizoue, T., Mibu, R., Tanaka, M., Kakeji, Y., Maehara, Y., Okamura, T., Ikejiri, K., Futami, K., Yasunami, Y., Maekawa, T., Takenaka, K., Ichimiya, H., Imaizumi, N. (https://doi.org/10.1111/j.1349-7006.2004.tb02201.x>
27. 2005) Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease. Hum. Genet. 116, 247-254.
< , M., Nolte, I. M., Schipper, M., Oosterom, E., Van Der Steege, G., De Vries, E. G., Te Meerman, G. J., Van Der Zee, A. G. (https://doi.org/10.1007/s00439-004-1233-4>